Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Updated treatment approach to hepatocellular carcinoma
Josep M. Llovet
Cancer Clinical Investigation
Icahn School of Medicine at Mount Sinai
Liver Cancer
Medicine
Medicine - Liver Diseases
The Tisch Cancer Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
462
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Updated treatment approach to hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
Treatment Strategy
100%
Randomized Controlled Trial
80%
Survival Benefit
80%
Japan
60%
Staging System
60%
Clinical Trials
40%
5-year Survival
40%
Resection
40%
Microvascular Invasion
40%
Liver Function
40%
Transplantation
20%
Liver Transplantation
20%
Patients with Cancer
20%
Intention-to-treat
20%
Disease Stage
20%
United States
20%
Early Detection
20%
Surgical Treatment
20%
Treatment Complications
20%
New Drugs
20%
Curative Treatment
20%
Natural History
20%
Prognostic Factors
20%
Africa
20%
Metaanalysis
20%
Response Rate
20%
Common Cancers
20%
Partial Response
20%
Antiangiogenic Agents
20%
TNM Staging
20%
Advanced Hepatocellular Carcinoma
20%
Barcelona Clinic Liver Cancer
20%
Disease Knowledge
20%
Therapeutic Approaches
20%
Retreatment
20%
Europe
20%
Tyrosine Kinase Inhibitor
20%
Percutaneous Ablation
20%
Advanced Tumor
20%
Objective Response Rate
20%
Doxorubicin
20%
Response-outcome
20%
Surveillance Program
20%
Percutaneous Treatment
20%
Geographical Distribution
20%
Specific Treatment
20%
Non-surgical Periodontal Therapy
20%
Chemoembolization
20%
Treatment Schedule
20%
Multinodular
20%
Early Tumor
20%
Child-Pugh Class
20%
Anti-androgen Therapy
20%
Cancer-related Symptoms
20%
Stage Classification
20%
Antitumoral Effect
20%
Internal Radiation Exposure
20%
Ethanol Injection
20%
Radiofrequency Thermocoagulation
20%
Asymptomatic Tumors
20%
Radical Approach
20%
Cancer of the Liver Italian Program
20%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Randomized Controlled Trial
66%
Malignant Neoplasm
50%
Tumor
50%
Diseases
50%
Clinical Trial
33%
Liver Function
33%
Liver Transplantation
16%
Intention-to-Treat Analysis
16%
Immunotherapy
16%
Tyrosine-Kinase Inhibitor
16%
Meta-Analysis
16%
Liver Cancer
16%
Angiogenesis Inhibitor
16%
Transcatheter Arterial Chemoembolization
16%
Cancer Staging
16%
Retreatment
16%
Doxorubicin
16%
Antiinfective Agent
16%
Geographic Distribution
16%
Tamoxifen
16%
Child-Pugh Score
16%
Antiandrogen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Malignant Neoplasm
66%
Randomized Controlled Trial
66%
Diseases
50%
Clinical Trial
33%
Antiinfective Agent
16%
Immunotherapy
16%
Protein Tyrosine Kinase Inhibitor
16%
Liver Cancer
16%
Doxorubicin
16%
Tamoxifen
16%
Cancer Staging
16%
Geographic Distribution
16%
Antiandrogen
16%
Angiogenesis Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Clinical Trial
50%
Liver Function
50%
Cancer Staging
25%
Tyrosine Kinase Inhibitor
25%
Radiofrequency
25%
Geographic Distribution
25%
Doxorubicin
25%